Max India Ltd

Max India Earnings Call: Key Takeaways

Max India reported Q4FY26 revenue of ₹72 Cr, up 58% YoY. EBITDA loss narrowed significantly to ₹7 Cr from ₹28 Cr QoQ.

Max India Board Meeting Outcome

Max India approved a ₹75 Crore corporate guarantee and reallocated ₹124.23 Crore in rights issue proceeds. These decisions support subsidiary funding and operational flexibility.

Value

₹75.00 Cr

Max India Fund Raise of ₹164.4 Cr

Max India Limited reported zero deviation in utilizing ₹164.40 Crore raised through rights and preferential issues. The audit committee reviewed and confirmed these findings.

Value

₹164.4 Cr

Max India Management Change

Max India Limited re-appointed MGC Global Risk Advisory LLP as Internal Auditor for twelve months. This follows board approval during the meeting held on May 28, 2026.

Execution

12 months

Max India Q4 FY26 Results: Net Loss of ₹19.3 Cr, Loss Narrows

Max India Ltd reported revenue from operations of ₹65.6 Cr (+58.1% YoY) and a net loss of ₹19.3 Cr for Q4 FY26.

Key figure

Net loss ₹19.3 Cr

Max India Financial Results

Max India Limited reported audited consolidated financial results for the year ended March 31, 2026. The board also confirmed the company's non-applicability under the large corporate framework.

Max India Other Announcement

Max India subsidiary Antara received an occupancy certificate for its Noida Phase 1 community. This unlocks ₹150 Crore in receivables and enables possession for 340 families.

Value

₹150.0 Cr

Max India Merger & Restructuring

Max India Limited's wholly owned subsidiary, Max UK Limited, has been dissolved following a voluntary strike-off. This liquidation streamlines the company's international corporate structure.

Max India Board Meeting Date

Max India Ltd scheduled a board meeting for May 28, 2026, to approve audited financial results. The trading window remains closed until May 30.

Max India Fund Raise of ₹21.61 Cr

Max India Ltd utilized ₹21.61 Crore from Rights Issue proceeds during Q4FY26. The Monitoring Agency confirmed zero deviation from the stated objects of the issue.

Value

₹21.61 Cr

Max India Management Change

Max India Limited has appointed Ms. Mrinalini Mirchandani as a Non-Executive Independent Director for a five-year term effective April 15, 2026. A former Senior Partner at McKinsey & Company, she brings extensive experience in private equity and healthcare leadership. This strategic appointment strengthens the board's professional expertise and corporate governance.

Execution

5 years

Max India Management Change

Max India Limited has appointed Ms. Mrinalini Mirchandani as an Independent Director for a five-year term starting April 15, 2026. A former Senior Partner at McKinsey & Company, she brings extensive expertise in private equity and healthcare. The appointment is subject to shareholder approval.

Execution

5 years

Max India Other Announcement

Max India Limited submitted its compliance certificate under Regulation 74(5) for the quarter ended March 31, 2026. The registrar, Mas Services Limited, confirmed that security certificates received for dematerialization were processed and updated within the 15-day regulatory timeframe.